Skip to main content
Clinical Trials/NCT00519961
NCT00519961
Unknown
Not Applicable

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Hoffmann-La Roche0 sites1,800 target enrollmentFebruary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Vascular Disease
Sponsor
Hoffmann-La Roche
Enrollment
1800
Primary Endpoint
Collection of 30-day and 1-year postoperative cardiac events
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
September 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients, \≥18 years of age
  • Patients with peripheral vascular atherosclerosis, scheduled for vascular surgery

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Collection of 30-day and 1-year postoperative cardiac events

Time Frame: 30-day and 1-year postoperation

Similar Trials